The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Fehér, Á.,
Domingos, G. J.,
Piga, M.,
Tomasic, T.,
Zidar, N.,
Varga, Z.:
A kinetic trap mechanism underlies hHv1 inhibition by NZ-58.
J. Gen. Physiol. "Accepted by publisher", 2026.
Kothalawala, R. C.,
Makay, C.,
Szente, L.,
Varga, Z.,
Panyi, G.,
Nagy, P.,
Zákány, F.,
Kovács, T.:
Disorder in Order-Related Membrane Biophysical Parameters: an In-Depth Analysis of Di-4-ANEPPDHQ Generalized Polarization.
J. Phys. Chem. Lett. 17 (16), 4723-4731, 2026.
Zákány, F.,
Kothalawala, R. C.,
Pavela, O.,
Szente, L.,
Varga, Z.,
Panyi, G.,
Beke-Somfai, T.,
Nagy, P.,
Kovács, T.:
The Many Layers of Membrane Biophysics: Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths.
Anal. Chem. 98 (24), 17638-17654, 2026.
Piga, M.,
Varga, Z.,
Fehér, Á.,
Papp, F.,
Korpos, É.,
Bangera, K. C.,
Frlan, R.,
Ilas, J.,
Dernovsek, J.,
Tomasic, T.,
Zidar, N.:
Correction to "Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening".
J. Chem Inf. Model. 64 (24), 9651, 2024.
Piga, M.,
Varga, Z.,
Fehér, Á.,
Papp, F.,
Korpos, É.,
Bangera, K. C.,
Frlan, R.,
Ilas, J.,
Dernovsek, J.,
Tomasic, T.,
Zidar, N.:
Identification of a Novel Structural Class of Hv1 Inhibitors by Structure-Based Virtual Screening.
J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
Kovács, T.,
Cs. Szabó, B.,
Kothalawala, R. C.,
Székelyhidi, V.,
Nagy, P.,
Varga, Z.,
Panyi, G.,
Zákány, F.:
Inhibition of the HV1 voltage-gated proton channel compromises the viability of human polarized macrophages in a polarization- and ceramide-dependent manner.
Front. Immunol. 15, 1-18, (article identifier: 1487578), 2024.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
21.
Nemes, B. Á.,
László, S.,
Zsidó, Z. B.,
Hetényi, C.,
Fehér, Á.,
Papp, F.,
Varga, Z.,
Szőke, É.,
Sándor, Z.,
Pintér, E.:
Elucidation of the binding mode of organic polysulfides on the human TRPA1 receptor.
Front. Physiol. 14, 1-16, (article identifier: 1180896), 2023.
Kovács, T.,
Kurtán, K.,
Varga, Z.,
Nagy, P.,
Panyi, G.,
Zákány, F.:
Veklury (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content.
Br. J. Pharmacol. 180 (16), 2064-2084, 2023.
Zákány, F.,
Kovács, T.,
Szente, L.,
Varga, Z.:
Cyclodextrins as promising therapeutics against cholesterol overload.
In: Cholesterol. Ed.: Anna N. Bukiya, Alex M. Dopico, Academic Press Inc Elsevier Science, San Diego, 927-967, 2022. ISBN: 9780323858571
